A detailed history of Douglass Winthrop Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 410,218 shares of BDX stock, worth $92.6 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares
410,218
Previous 403,173 1.75%
Holding current value
$92.6 Million
Previous $94.2 Million 4.96%
% of portfolio
1.94%
Previous 1.97%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$221.47 - $242.41 $1.56 Million - $1.71 Million
7,045 Added 1.75%
410,218 $98.9 Million
Q2 2024

Aug 07, 2024

BUY
$225.07 - $246.17 $10.1 Million - $11 Million
44,758 Added 12.49%
403,173 $94.2 Million
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $79.9 Million - $84.8 Million
342,206 Added 2111.21%
358,415 $88.7 Million
Q4 2023

Feb 12, 2024

SELL
$232.24 - $267.23 $285,655 - $328,692
-1,230 Reduced 7.05%
16,209 $3.95 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $235,782 - $262,320
-925 Reduced 5.04%
17,439 $4.51 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $128,730 - $143,272
-540 Reduced 2.86%
18,364 $4.85 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $612,177 - $691,167
-2,665 Reduced 12.36%
18,904 $4.68 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $659,890 - $776,638
-3,023 Reduced 12.29%
21,569 $5.49 Million
Q3 2022

Nov 15, 2022

SELL
$51.03 - $264.23 $147,374 - $763,096
-2,888 Reduced 10.51%
24,592 $5.48 Million
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $885,439 - $1.04 Million
-3,772 Reduced 12.07%
27,480 $6.78 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $7.53 Million - $8.36 Million
-30,906 Reduced 49.72%
31,252 $8.31 Million
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $21.3 Million - $23.2 Million
-92,463 Reduced 59.8%
62,158 $15.6 Million
Q3 2021

Nov 10, 2021

SELL
$232.72 - $256.47 $6.73 Million - $7.42 Million
-28,935 Reduced 15.76%
154,621 $38 Million
Q2 2021

Aug 02, 2021

SELL
$232.65 - $254.58 $50.3 Million - $55.1 Million
-216,257 Reduced 54.09%
183,556 $44.6 Million
Q1 2021

May 13, 2021

BUY
$232.09 - $256.88 $4.85 Million - $5.37 Million
20,902 Added 5.52%
399,813 $97.2 Million
Q4 2020

Jan 27, 2021

BUY
$221.92 - $245.94 $2.67 Million - $2.96 Million
12,022 Added 3.28%
378,911 $94.8 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $5.12 Million - $6.57 Million
23,721 Added 6.91%
366,889 $85.4 Million
Q2 2020

Jul 17, 2020

SELL
$219.9 - $263.41 $161,186 - $193,079
-733 Reduced 0.21%
343,168 $82.1 Million
Q1 2020

Apr 23, 2020

BUY
$195.69 - $279.01 $4.99 Million - $7.12 Million
25,522 Added 8.02%
343,901 $79 Million
Q4 2019

Jan 10, 2020

BUY
$236.45 - $266.82 $307,621 - $347,132
1,301 Added 0.41%
318,379 $86.6 Million
Q3 2019

Oct 08, 2019

BUY
$230.58 - $256.08 $780,513 - $866,830
3,385 Added 1.08%
317,078 $80.2 Million
Q2 2019

Jul 10, 2019

BUY
$217.4 - $246.08 $3.63 Million - $4.11 Million
16,691 Added 5.62%
313,693 $79.1 Million
Q1 2019

Apr 09, 2019

BUY
$206.05 - $248.17 $1.69 Million - $2.03 Million
8,196 Added 2.84%
297,002 $74.2 Million
Q4 2018

Jan 16, 2019

BUY
$204.73 - $257.93 $3.75 Million - $4.73 Million
18,333 Added 6.78%
288,806 $65.1 Million
Q3 2018

Oct 12, 2018

BUY
$233.07 - $256.0 $279,450 - $306,944
1,199 Added 0.45%
270,473 $70.6 Million
Q2 2018

Jul 24, 2018

BUY
$208.1 - $233.85 $320,265 - $359,895
1,539 Added 0.57%
269,274 $64.5 Million
Q1 2018

May 08, 2018

BUY
$205.46 - $240.27 $4.12 Million - $4.82 Million
20,076 Added 8.11%
267,735 $58 Million
Q4 2017

Feb 13, 2018

SELL
$189.0 - $222.64 $261,765 - $308,356
-1,385 Reduced 0.56%
247,659 $53 Million
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $46.5 Million - $49.5 Million
249,044
249,044 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Douglass Winthrop Advisors, LLC Portfolio

Follow Douglass Winthrop Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.